Research ArticleArticle
Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
Walter P. Maksymowych, David Salonen, Robert D. Inman, Proton Rahman and Robert G.W. Lambert
The Journal of Rheumatology May 2010, jrheum.091043; DOI: https://doi.org/10.3899/jrheum.091043
Walter P. Maksymowych
David Salonen
Robert D. Inman
Proton Rahman
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
Walter P. Maksymowych, David Salonen, Robert D. Inman, Proton Rahman, Robert G.W. Lambert
The Journal of Rheumatology May 2010, jrheum.091043; DOI: 10.3899/jrheum.091043
Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
Walter P. Maksymowych, David Salonen, Robert D. Inman, Proton Rahman, Robert G.W. Lambert
The Journal of Rheumatology May 2010, jrheum.091043; DOI: 10.3899/jrheum.091043